Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T‐cell lymphoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|171|4|509-516

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.171, Iss.4, 2015-11, pp. : 509-516

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase II study

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 5, 2015-06 ,pp. : 672-682

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T‐cell lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 6, 2015-03 ,pp. : 811-819

John Wiley & Sons Inc

Access to resources Recommend Favorite

Peripheral T‐cell lymphoma mimicking Schnitzler syndrome

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 20, Iss. 12, 2017-12 ,pp. : 2194-2196

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and tolerance of GELOXD/P‐GEMOXD in newly diagnosed nasal‐type extranodal NK/T‐cell lymphoma: A multicenter retrospective study

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 3, 2018-03 ,pp. : 247-256

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors predicting survival in peripheral T‐cell lymphoma in the USA: a population‐based analysis of 8802 patients in the modern era

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 5, 2015-03 ,pp. : 708-718

John Wiley & Sons Inc

Access to resources Recommend Favorite